Telomerase activating compounds and methods of use thereof
US8609736B2 · kind B2 · utility
6Cited by
1References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 4, 2008 |
| Grant date | Dec 17, 2013 |
| Priority date | — |
| Expiry date | Oct 2, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/5022
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to use of a series of compounds and compositions comprising the same for activating telomerase and treating diseases, disorders and/or conditions related thereto.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.